Sleep-related vagotonic effect of zolpidem in rats

Hsiao Ying Chen, Terry B J Kuo, Fu Zen Shaw, Ching J. Lai, Cheryl C H Yang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Rationale: Zolpidem is a relatively new nonbenzodiazepine sedative-hypnotic. The effects of zolpidem on autonomic functions remain unclear. Objectives: The aim of this study was to evaluate the effects of zolpidem on sleep and related cardiac autonomic modulations as compared with triazolam in Wistar-Kyoto rats. Methods: Continuous power spectral analyses of electroencephalogram (EEG), electromyogram, and heart rate variability were performed on freely moving rats during daytime sleep. The consciousness states were classified into active waking (AW), quiet sleep (QS), and paradoxical sleep (PS). Drugs were administered via gavage and data within 2 h were analyzed. Results: All zolpidem (ZP3, 3 mg/kg; ZP30, 30 mg/kg) and triazolam (TZ0.075, 0.075 mg/kg; TZ0.75, 0.75 mg/kg) groups had longer accumulated QS time and averaged QS duration as compared with the vehicle control. The accumulated QS time and averaged QS duration of ZP3 were similar to those of TZ0.075. Significant suppressions of PS time were noted in all drug groups except ZP3. During QS, ZP3 and ZP30 exhibited significant increases of magnitude and percentage of EEG δ power, whereas TZ0.075 and TZ0.75 did not. Heart period and high-frequency power of heart rate variability increased significantly in ZP3 during all sleep-wake states. Both parameters, however, did not increase but even decreased in ZP30, TZ0.075, and TZ0.75. Conclusions: Zolpidem not only caused a longer and deeper sleep but also led to an elevated cardiac vagal activity at a specific dose in the rat.

Original languageEnglish
Pages (from-to)270-279
Number of pages10
JournalPsychopharmacology
Volume181
Issue number2
DOIs
Publication statusPublished - Sep 2005
Externally publishedYes

Fingerprint

Sleep
Triazolam
REM Sleep
Electroencephalography
Heart Rate
zolpidem
Inbred WKY Rats
Electromyography
Consciousness
Hypnotics and Sedatives
Pharmaceutical Preparations
Power (Psychology)

Keywords

  • Heart rate variability
  • Hypnotic
  • Triazolam
  • Zolpidem

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chen, H. Y., Kuo, T. B. J., Shaw, F. Z., Lai, C. J., & Yang, C. C. H. (2005). Sleep-related vagotonic effect of zolpidem in rats. Psychopharmacology, 181(2), 270-279. https://doi.org/10.1007/s00213-005-2236-0

Sleep-related vagotonic effect of zolpidem in rats. / Chen, Hsiao Ying; Kuo, Terry B J; Shaw, Fu Zen; Lai, Ching J.; Yang, Cheryl C H.

In: Psychopharmacology, Vol. 181, No. 2, 09.2005, p. 270-279.

Research output: Contribution to journalArticle

Chen, HY, Kuo, TBJ, Shaw, FZ, Lai, CJ & Yang, CCH 2005, 'Sleep-related vagotonic effect of zolpidem in rats', Psychopharmacology, vol. 181, no. 2, pp. 270-279. https://doi.org/10.1007/s00213-005-2236-0
Chen, Hsiao Ying ; Kuo, Terry B J ; Shaw, Fu Zen ; Lai, Ching J. ; Yang, Cheryl C H. / Sleep-related vagotonic effect of zolpidem in rats. In: Psychopharmacology. 2005 ; Vol. 181, No. 2. pp. 270-279.
@article{59b0b0e4689644ec892925dda8b2a2d0,
title = "Sleep-related vagotonic effect of zolpidem in rats",
abstract = "Rationale: Zolpidem is a relatively new nonbenzodiazepine sedative-hypnotic. The effects of zolpidem on autonomic functions remain unclear. Objectives: The aim of this study was to evaluate the effects of zolpidem on sleep and related cardiac autonomic modulations as compared with triazolam in Wistar-Kyoto rats. Methods: Continuous power spectral analyses of electroencephalogram (EEG), electromyogram, and heart rate variability were performed on freely moving rats during daytime sleep. The consciousness states were classified into active waking (AW), quiet sleep (QS), and paradoxical sleep (PS). Drugs were administered via gavage and data within 2 h were analyzed. Results: All zolpidem (ZP3, 3 mg/kg; ZP30, 30 mg/kg) and triazolam (TZ0.075, 0.075 mg/kg; TZ0.75, 0.75 mg/kg) groups had longer accumulated QS time and averaged QS duration as compared with the vehicle control. The accumulated QS time and averaged QS duration of ZP3 were similar to those of TZ0.075. Significant suppressions of PS time were noted in all drug groups except ZP3. During QS, ZP3 and ZP30 exhibited significant increases of magnitude and percentage of EEG δ power, whereas TZ0.075 and TZ0.75 did not. Heart period and high-frequency power of heart rate variability increased significantly in ZP3 during all sleep-wake states. Both parameters, however, did not increase but even decreased in ZP30, TZ0.075, and TZ0.75. Conclusions: Zolpidem not only caused a longer and deeper sleep but also led to an elevated cardiac vagal activity at a specific dose in the rat.",
keywords = "Heart rate variability, Hypnotic, Triazolam, Zolpidem",
author = "Chen, {Hsiao Ying} and Kuo, {Terry B J} and Shaw, {Fu Zen} and Lai, {Ching J.} and Yang, {Cheryl C H}",
year = "2005",
month = "9",
doi = "10.1007/s00213-005-2236-0",
language = "English",
volume = "181",
pages = "270--279",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Sleep-related vagotonic effect of zolpidem in rats

AU - Chen, Hsiao Ying

AU - Kuo, Terry B J

AU - Shaw, Fu Zen

AU - Lai, Ching J.

AU - Yang, Cheryl C H

PY - 2005/9

Y1 - 2005/9

N2 - Rationale: Zolpidem is a relatively new nonbenzodiazepine sedative-hypnotic. The effects of zolpidem on autonomic functions remain unclear. Objectives: The aim of this study was to evaluate the effects of zolpidem on sleep and related cardiac autonomic modulations as compared with triazolam in Wistar-Kyoto rats. Methods: Continuous power spectral analyses of electroencephalogram (EEG), electromyogram, and heart rate variability were performed on freely moving rats during daytime sleep. The consciousness states were classified into active waking (AW), quiet sleep (QS), and paradoxical sleep (PS). Drugs were administered via gavage and data within 2 h were analyzed. Results: All zolpidem (ZP3, 3 mg/kg; ZP30, 30 mg/kg) and triazolam (TZ0.075, 0.075 mg/kg; TZ0.75, 0.75 mg/kg) groups had longer accumulated QS time and averaged QS duration as compared with the vehicle control. The accumulated QS time and averaged QS duration of ZP3 were similar to those of TZ0.075. Significant suppressions of PS time were noted in all drug groups except ZP3. During QS, ZP3 and ZP30 exhibited significant increases of magnitude and percentage of EEG δ power, whereas TZ0.075 and TZ0.75 did not. Heart period and high-frequency power of heart rate variability increased significantly in ZP3 during all sleep-wake states. Both parameters, however, did not increase but even decreased in ZP30, TZ0.075, and TZ0.75. Conclusions: Zolpidem not only caused a longer and deeper sleep but also led to an elevated cardiac vagal activity at a specific dose in the rat.

AB - Rationale: Zolpidem is a relatively new nonbenzodiazepine sedative-hypnotic. The effects of zolpidem on autonomic functions remain unclear. Objectives: The aim of this study was to evaluate the effects of zolpidem on sleep and related cardiac autonomic modulations as compared with triazolam in Wistar-Kyoto rats. Methods: Continuous power spectral analyses of electroencephalogram (EEG), electromyogram, and heart rate variability were performed on freely moving rats during daytime sleep. The consciousness states were classified into active waking (AW), quiet sleep (QS), and paradoxical sleep (PS). Drugs were administered via gavage and data within 2 h were analyzed. Results: All zolpidem (ZP3, 3 mg/kg; ZP30, 30 mg/kg) and triazolam (TZ0.075, 0.075 mg/kg; TZ0.75, 0.75 mg/kg) groups had longer accumulated QS time and averaged QS duration as compared with the vehicle control. The accumulated QS time and averaged QS duration of ZP3 were similar to those of TZ0.075. Significant suppressions of PS time were noted in all drug groups except ZP3. During QS, ZP3 and ZP30 exhibited significant increases of magnitude and percentage of EEG δ power, whereas TZ0.075 and TZ0.75 did not. Heart period and high-frequency power of heart rate variability increased significantly in ZP3 during all sleep-wake states. Both parameters, however, did not increase but even decreased in ZP30, TZ0.075, and TZ0.75. Conclusions: Zolpidem not only caused a longer and deeper sleep but also led to an elevated cardiac vagal activity at a specific dose in the rat.

KW - Heart rate variability

KW - Hypnotic

KW - Triazolam

KW - Zolpidem

UR - http://www.scopus.com/inward/record.url?scp=27144524159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144524159&partnerID=8YFLogxK

U2 - 10.1007/s00213-005-2236-0

DO - 10.1007/s00213-005-2236-0

M3 - Article

C2 - 15778879

AN - SCOPUS:27144524159

VL - 181

SP - 270

EP - 279

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -